FDA Approved: DEXYCU — Original Application (EyePoint Pharmaceuticals US, Inc)

View source ↗

Summary

The FDA granted original approval for DEXYCU (dexamethasone intraocular suspension) from EyePoint Pharmaceuticals US, Inc to treat postoperative inflammation fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Inflammation Following Cataract Surgery

Drugs mentioned

• Dexycu (dexamethasone intraocular suspension)

Snippet

ORIG AP for DEXYCU (DEXAMETHASONE)